We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$836M
AUM Growth
+$4.91M
Cap. Flow
-$16.6M
Cap. Flow %
-1.98%
Top 10 Hldgs %
38.74%
Holding
112
New
6
Increased
28
Reduced
28
Closed
20

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$11.9M
2
KYNB
Kyntra Bio
KYNB
+$9.69M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$9.43M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$6.67M
5
IMMU
Immunomedics Inc
IMMU
+$6.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$17M
2
UNH icon
UnitedHealth
UNH
+$8.53M
3
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$5.93M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$5.75M
5
PODD icon
Insulet
PODD
+$5.61M

Sector Composition

Rank Sector Weight
1 Healthcare 85.37%
2 Industrials 2.83%
3 Technology 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWAV
1
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$48.5M 5.8%
849,811
– –
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
$41.5M 4.96%
3,324,623
-70,000
-2% -$888K
APLS
3
DELISTED
Apellis Pharmaceuticals
APLS
$37.8M 4.51%
1,489,957
-237,872
-14% -$4.84M
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
$36.8M 4.4%
794,868
-115,100
-13% -$3.23M
TDOC icon
5
Teladoc Health
TDOC
$1.61B
$34.1M 4.08%
513,166
-78,315
-13% -$4.56M
ALNY icon
6
Alnylam Pharmaceuticals
ALNY
$35.6B
$29.2M 3.49%
402,641
+11,600
+3% +$890K
AERI
7
DELISTED
Aerie Pharmaceuticals
AERI
$28.3M 3.38%
956,036
+116,082
+14% +$4.47M
GILD icon
8
Gilead Sciences
GILD
$162B
$26.9M 3.22%
398,040
-38,100
-9% -$2.51M
TNDM icon
9
Tandem Diabetes Care
TNDM
$1.16B
$20.6M 2.47%
319,866
+184,199
+136% +$11.9M
PTCT icon
10
PTC Therapeutics
PTCT
$6.5B
$20.3M 2.42%
450,638
-12,499
-3% -$494K
RARX
11
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$20M 2.39%
665,713
-20,800
-3% -$476K
PTLA
12
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$19.6M 2.34%
721,556
+112,199
+18% +$3.52M
SRPT icon
13
Sarepta Therapeutics
SRPT
$1.67B
$17.8M 2.13%
117,097
-11,001
-9% -$1.34M
NVS icon
14
Novartis
NVS
$292B
$16.7M 1.99%
182,646
-45,069
-20% -$3.81M
HRC
15
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$16.6M 1.99%
158,799
– –
PFE icon
16
Pfizer
PFE
$141B
$15.7M 1.88%
382,525
-59,234
-13% -$2.35M
COLL icon
17
Collegium Pharmaceutical
COLL
$1.13B
$15.4M 1.85%
1,174,847
+240,513
+26% +$3.22M
LJPC
18
DELISTED
La Jolla Pharmaceutical Company
LJPC
$15.3M 1.83%
1,657,171
-102,000
-6% -$769K
WMGI
19
DELISTED
Wright Medical Group Inc
WMGI
$15.2M 1.82%
511,173
+9,901
+2% +$302K
MRK icon
20
Merck
MRK
$315B
$14M 1.67%
174,806
+2,200
+1% +$168K
KYNB
21
Kyntra Bio
KYNB
$29.2M
$13.7M 1.64%
12,106
+8,856
+272% +$9.69M
RCM
22
DELISTED
R1 RCM Inc. Common Stock
RCM
$13.6M 1.62%
1,078,872
-8,226
-0.8% -$92.9K
BMRN icon
23
BioMarin Pharmaceuticals
BMRN
$11.3B
$13.1M 1.57%
153,101
+72,780
+91% +$6.23M
AGN
24
DELISTED
Allergan plc
AGN
$13.1M 1.57%
78,300
-6,600
-8% -$914K
VCRA
25
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$12.2M 1.46%
381,604
+25
+0% +$797
1
2 3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sectoral Asset Management held 112 positions worth $836M, up 0.59% from $831M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sectoral Asset Management's Q2 2019 filing shows 6 new, 28 increased, 28 reduced and 20 closed positions. Its largest new stake was Alexion Pharmaceuticals: 73,199 shares worth $9.59M. The largest sale was Celgene Corp, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 85% a quarter earlier, followed by Industrials and Technology.

  • Sectoral Asset Management's largest Q2 2019 buy was Alexion Pharmaceuticals: 73,199 shares worth $9.59M.
  • Sectoral Asset Management added most to Tandem Diabetes Care in Q2 2019, an estimated $11.9M increase.
  • Sectoral Asset Management's biggest Q2 2019 reduction was Insulet, cutting an estimated $5.61M.
  • Sectoral Asset Management fully exited Celgene Corp in Q2 2019, selling an estimated $17M.
  • Sectoral Asset Management's ten largest holdings make up 39% of its $836M portfolio in Q2 2019.
  • Sectoral Asset Management opened 6 new positions and closed 20 in Q2 2019.
  • Sectoral Asset Management's portfolio value rose 0.59% quarter-over-quarter to $836M.

Based on Sectoral Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.